好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Ethnic Disparities in the Incidence and Prevalence of Multiple Sclerosis
Multiple Sclerosis
P4 - Poster Session 4 (11:45 AM-12:45 PM)
6-018

This review evaluated ethnic disparities in the incidence and prevalence of Multiple sclerosis (MS).

MS exhibits a well-established latitudinal gradient distribution in incidence and prevalence. Emerging evidence suggests that ethnicity may also play a significant role. 

Ethnicities were classified as White, Black, Hispanic, Asian, and Middle Eastern and North African (MENA). A search was conducted using PubMed to identify articles on MS and ethnicity published in English language, between 01/01/2005 and 31/05/2022. 

 

We identified fourteen studies on MS incidence and twenty-two on prevalence, which revealed that the incidence and prevalence of MS varied not only between ethnicities, but also depended upon the country of study.   

 

In the US, individuals of Black ethnicity had equivalent or greater MS incidence and prevalence compared to White ethnicity. Conversely, European papers revealed lower MS incidence and prevalence among individuals of Black ethnicity compared to those of White background. Remarkably, in both US and European research, individuals of Black ethnicity had similar or greater MS incidence and prevalence compared to those of Asian ethnicity. In Africa, MS incidence and prevalence were lower in individuals of Black ethnicity compared to White and Asian ethnicities.

 

In US studies, Hispanic individuals consistently displayed significantly lower MS prevalence compared to those from White and Black ethnicities, but higher prevalence than in Asian individuals. Additionally, both US and European research reported lower incidence and prevalence of MS in individuals of Asian ethnicity than in those of White ethnicity. Moreover, a European study revealed that MS prevalence in individuals from MENA backgrounds was lower than in those of White ethnicity, while another study in a MENA country reported similar MS prevalence between the two ethnicities. 

Additional research to understand these ethnic disparities in MS is crucial in identifying underlying causes, allowing the delivery of personalised care, and mitigating potential inequity.

Authors/Disclosures
Gagana K. Mallawaarachchi
PRESENTER
Mr. Mallawaarachchi has nothing to disclose.
David Rog, MBBS Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Rog has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Rog has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Rog has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Rog has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neuraxpharm. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Rog has received research support from Merck. The institution of Dr. Rog has received research support from Novartis. The institution of Dr. Rog has received research support from TG Therapeutics. Dr. Rog has received research support from Janssen-Cilag.
Joyutpal Das, MBBS Dr. Das has nothing to disclose.